Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL29P4 is a pseudogene derived from the ribosomal protein L29 (RPL29) gene. Pseudogenes are DNA sequences that resemble functional genes but have lost their protein-coding ability through evolutionary processes. They are typically characterized by the presence of stop codons, frameshifts, or other mutations that prevent them from producing functional proteins. The functional parent gene, RPL29, encodes a component of the 60S ribosomal subunit that is essential for protein synthesis. RPL29 belongs to the L29E family of ribosomal proteins and serves as both a structural component of ribosomes and a peripheral membrane protein that can bind heparin. The functional RPL29 protein plays crucial roles in ribosome biogenesis, translational control, and has been implicated in various cellular processes including p53-mediated stress responses and cancer progression. However, RPL29P4, being a pseudogene, does not produce a functional protein and therefore lacks therapeutic relevance. As is typical for ribosomal protein genes, multiple processed pseudogenes of RPL29 are dispersed throughout the human genome, with RPL29P4 being one of these non-functional copies. The pseudogene designation makes RPL29P4 unsuitable as a therapeutic target, as it does not encode a functional protein that could be modulated by drugs or other therapeutic interventions.
Not applicable (pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L29 pseudogene 4 (RPL29P4).